Public perceptions of the FDA's marketing authorization of Vuse on Twitter/X

IntroductionOn October 12, 2021, the FDA issued its first marketing granted orders for Vuse, the e-cigarette product by R.J. Reynolds Vapor Company. The public perceptions and reactions to the FDA's Vuse authorization are prevalent on social media platforms such as Twitter/X. We aim to understa...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sarah Lee (Författare, medförfattare), Zidian Xie (Författare, medförfattare), Emily Xu (Författare, medförfattare), Yihan Shao (Författare, medförfattare), Deborah J. Ossip (Författare, medförfattare), Dongmei Li (Författare, medförfattare)
Materialtyp: Bok
Publicerad: Frontiers Media S.A., 2023-11-01T00:00:00Z.
Ämnen:
Länkar:Connect to this object online.
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3288b146854b4f4e80e5b831a09f82bc
042 |a dc 
100 1 0 |a Sarah Lee  |e author 
700 1 0 |a Zidian Xie  |e author 
700 1 0 |a Emily Xu  |e author 
700 1 0 |a Yihan Shao  |e author 
700 1 0 |a Deborah J. Ossip  |e author 
700 1 0 |a Dongmei Li  |e author 
245 0 0 |a Public perceptions of the FDA's marketing authorization of Vuse on Twitter/X 
260 |b Frontiers Media S.A.,   |c 2023-11-01T00:00:00Z. 
500 |a 2296-2565 
500 |a 10.3389/fpubh.2023.1280658 
520 |a IntroductionOn October 12, 2021, the FDA issued its first marketing granted orders for Vuse, the e-cigarette product by R.J. Reynolds Vapor Company. The public perceptions and reactions to the FDA's Vuse authorization are prevalent on social media platforms such as Twitter/X. We aim to understand public perceptions of the FDA's Vuse authorization in the US using Twitter/X data.MethodsThrough the Twitter/X streaming API (Application Programming Interface), 3,852 tweets between October 12, 2021, and October 23, 2021, were downloaded using the keyword of Vuse. With the elimination of retweets, irrelevant tweets, and tweets from other countries, the final dataset consisted of 523 relevant tweets from the US. Based on their attitudes toward the FDA authorization on Vuse, these tweets were coded into three major categories: positive, negative, and neutral. These tweets were further manually classified into different categories based on their contents.ResultsThere was a large peak on Twitter/X mentioning FDA's Vuse authorization on October 13, 2021, just after the authorization was announced. Of the 523 US tweets related to FDA's Vuse authorization, 6.12% (n=32) were positive, 26.77% (n=140) were negative, and 67.11% (n=351) were neutral. In positive tweets, the dominant subcategory was Cessation Claims (n=18, 56.25%). In negative tweets, the topics Health Risk (n=43, 30.71%), Criticize Authorization (n=42, 30.00%), and Big Tobacco (n=40, 38.57%) were the major topics. News (n=271, 77.21%) was the most prevalent topic among neutral tweets. In addition, tweets with a positive attitude tend to have more likes.DiscussionPublic perceptions and discussions on Twitter/X regarding the FDA's Vuse authorization in the US showed that Twitter/X users were more likely to show a negative than a positive attitude with a major concern about health risks. 
546 |a EN 
690 |a e-cigarettes 
690 |a FDA 
690 |a authorization 
690 |a Twitter/X 
690 |a Vuse 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Frontiers in Public Health, Vol 11 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fpubh.2023.1280658/full 
787 0 |n https://doaj.org/toc/2296-2565 
856 4 1 |u https://doaj.org/article/3288b146854b4f4e80e5b831a09f82bc  |z Connect to this object online.